Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-16

Clinical Trial Update: Regulating Urine pH Levels to Alleviate Chronic Joint Pain [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating whether regulating urine pH levels can alleviate chronic joint pain (arthritis) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas Tech University Health Sciences Center, El Paso | Conditions: Arthritis | Phase 1 | Status: WITHDRAWN